Study Stopped
After initially being suspended in the setting of the COVID-19 pandemic, the study was then terminated due to lack of funding and staffing to complete it.
Parent Understanding of Discharge Instructions
1 other identifier
interventional
264
1 country
1
Brief Summary
The overarching goal of this work is to identify strategies to reduce preventable pediatric post-hospitalization morbidity. In this study, investigators seek to address gaps in the knowledge base related to pediatric post-hospitalization morbidity by examining the understanding and execution of post-hospitalization discharge instructions in the context of low health literacy (HL).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 16, 2019
CompletedFirst Submitted
Initial submission to the registry
August 19, 2019
CompletedFirst Posted
Study publicly available on registry
August 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2020
CompletedMay 31, 2024
May 1, 2024
8 months
August 19, 2019
May 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Parent Execution of Discharge Instructions
Execution will be assessed at three time points. The first assessment (T2) will take place in person, within the first two weeks of discharge, to coincide with a follow-up appointment if possible or at another convenient time for the parent. At this time point, execution will be assessed via structured survey and b) observed dosing assessment. Surveys will include information about execution of instructions related to medications (dose and adherence), follow up appointments (attendance), concerning symptoms, and restrictions. The electronic health record will also be reviewed to determine if appointments were attended
14 days
Secondary Outcomes (4)
Parent Understanding of Discharge Instructions
1 day (within 12 hours of hospital discharge)
Post-Hospitalization Morbidity
45 days
Provider Outcomes: Baseline
Baseline: Day 1
Provider Outcomes
45 days
Study Arms (3)
Parent: Pre-implementation
NO INTERVENTIONParents in the pre-implementation group will receive standard care: verbal counseling by the doctor/nurse using text-based instructions they have prepared (not standardized).
Parent: Post-Implementation
EXPERIMENTALDoctors and nurses will be able to customize the web-based disease-specific instructions with the research team's help. They will reference these instructions as they perform discharge counseling and will give parents a copy of the instructions to refer to at home.
Provider
OTHERBaseline measures will be assessed for providers. They will then take part in a 20-minute training session, including information about health literacy, advanced counseling strategies, results of prior studies, and pre-implementation data. At the end of the study, assessments will be performed for those who use the health literacy-informed tool at least once during the study period.
Interventions
Web-based disease-specific instruction sheets that will be printed with the research team's help. Providers will reference these instructions as they perform discharge counseling and will give parents a copy of the instructions to refer to at home.
20-minute long provider training session, including information about health literacy, advanced counseling strategies, results of prior studies, and pre-implementation data.
Eligibility Criteria
You may qualify if:
- Primary caregiver of child ≤12 years old
- Primary caregiver of child discharged on ≥1 daily medication
- Primarily speaks and reads English or Spanish (by report).
You may not qualify if:
- Parent of child not discharged home (e.g. transferred to another facility\<18 years old
- Vision difficulty (\<20/50 corrected; Rosenbaum screener)
- Self-reported parent hearing difficulty
- Provider
- Pediatric resident at NYU School of Medicine
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Glick, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2019
First Posted
August 21, 2019
Study Start
July 16, 2019
Primary Completion
March 12, 2020
Study Completion
April 2, 2020
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Requests should be directed to alexander.glick@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.